ch.oddb.org
 
Apotheken | Arzt | Interaktionen | Medikamente | MiGeL | Services | Spital | Zulassungsi.
Fachinformation zu Methergin®:Novartis Pharma Schweiz AG
Vollst. FachinformationDDDDrucken 
Zusammens.Galen.FormInd./Anw.mögl.Dos./Anw.Kontraind.Warn.hinw.Interakt.Schwangerschaft
Fahrtücht.Unerw.WirkungenÜberdos.Eigensch.Pharm.kinetikPräklin.Sonstige H.Swissmedic-Nr.
Reg.InhaberStand d. Info. 
G02AB01 - MethylergometrineATC-DDD Version 2016. Source: WHO
G - Genito Urinary System and Sex Hormones
 
G02 - Other Gynecologicals

Analgesics used in dysmenorrhea, see N02B - Other analgesics and antipyretics and M01A - Antiinflammatory and antirheumatic products, non-steroids.

G02A - Uterotonics

Plain preparations of oxytocin and analogues are classified in H01B - Posterior pituitary lobe hormones.

G02AB - Ergot Alkaloids

This group comprises ergot alkaloids, e.g. methylergometrine, used for stimulation of uterine contractions. Other ergot alkaloids are classified in C04A - Peripheral vasodilators, and in N02C - Anti-migraine preparations.

The DDDs are based on use in delivery.

G02AB01 - Methylergometrine
StärkeAdm.RouteNote
 P 
 O 
2025 ©ywesee GmbH
Einstellungen | Hilfe | FAQ | Anmeldung | Kontakt | Home